ClassID:

95053

C07D311/36 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems; Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones

Recent Application in this class:
#1
20260049065
2026-02-19

SYSTEM AND METHOD FOR THE EXTRACTION OF ISOFLAVONES FROM SOYBEANS

#2
20250154121
2025-05-15

CYCLIC(ALKYL)(AMINO)ALKOXY-SUBSTITUTED ARYL-PYRONE COMPOUND AND USE THEREOF

#3
20250066343
2025-02-27

NOVEL CANNABICHROMENIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR IMPROVING COGNITIVE FUNCTION

#4
20250042880
2025-02-06

DIAMINOBUTOXY-SUBSTITUTED ISOFLAVONOIDS AS MITOCHONDRIAL COMPLEX I INHIBITORS FOR CANCER TREATMENT

#5
20240360095
2024-10-31

NOVEL KINASE MODULATORS

#6
20240287014
2024-08-29

Biflavone compound against I-type herpes simplex virus, and preparation method therefor and use thereof

#7
20240122894
2024-04-18

METHODS TO SYNTHESIZE FLAVONOID DIMERS AND OLIGOMERS AND THE USE THEREOF

#8
20230322837
2023-10-12

PREPARATION METHOD FOR AND APPLICATION OF CLASS OF STELLATE BIFUNCTIONAL COMPOUNDS TARGETING SPIKE PROTEIN AGAINST RESPIRATORY TRACT INFECTION VIRUS AND SALT THEREOF

#9
20230159761
2023-05-25

Method for chlorinating blue anthrone, violanthrone or isoviolantrone

#10
20220153716
2022-05-19

SYSTEM AND METHOD FOR THE EXTRACTION OF ISOFLAVONES FROM SOYBEANS

#11
20220119399
2022-04-21

COMPOUNDS AND COMPOSITIONS THAT CAUSE MYCN AND/OR CMYC DEGRADATION AND METHODS OF USE THEREOF

#12
20210401840
2021-12-30

NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES

#13
20200239427
2020-07-30

Kinase modulators

#14
20190282581
2019-09-19

Intermediates useful in the synthesis of compounds as modulators of protein kinases

#15
20190105324
2019-04-11

Substituted chromenones as modulators of protein kinases

#16
20190099453
2019-04-04

Medicament for liver regeneration and for treatment of liver failure

#17
20190091265
2019-03-28

MEDICAMENT FOR LIVER REGENERATION AND FOR TREATMENT OF LIVER FAILURE

#18
20190038634
2019-02-07

Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals

#19
20180319762
2018-11-08

5-deoxy-irilin B Having Angiotensin-I-converting enzyme Inhibition Activity derived from Salicornia SPP. and Composition Containing the Same

#20
20180186762
2018-07-05

7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto

#21
20180110783
2018-04-26

Substituted chromenones as modulators of protein kinases

#22
20170305876
2017-10-26

7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto

#23
20170000801
2017-01-05

Triarylmethane analogs and their use in treating cancers

#24
20160318890
2016-11-03

Kinase modulators

#25
20160264616
2016-09-15

THERAPEUTIC COMPOUNDS AND METHODS

#26
20160122312
2016-05-05

ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

#27
20160068542
2016-03-10

Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells

#28
20160045478
2016-02-18

S-nitrosoglutathione reductase inhibitors

#29
20160022742
2016-01-28

Medicament for liver regeneration and for treatment of liver failure

#30
20150352073
2015-12-10

Chromone inhibitors of S-nitrosoglutathione reductase

#31
20150320752
2015-11-12

Compounds as modulators of protein kinases

#32
20150274692
2015-10-01

7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto

#33
20150174131
2015-06-25

Kinase modulators

#34
20150094365
2015-04-02

Small molecule modulators of the cold and menthol receptor TRPM8

#35
20150087699
2015-03-26

Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals

#36
20140336247
2014-11-13

Daidzein derivative, pharmaceutically acceptable salt and preparation method thereof, and pharmaceutical composition containing same

#37
20140275185
2014-09-18

S-nitrosoglutathione reductase inhibitors

#38
20140163092
2014-06-12

Chromone Inhibitors of S-Nitrosoglutathione Reductase

#39
20140099370
2014-04-10

Controlled release of biologically active compounds

#40
20140080827
2014-03-20

Substituted chromenes as kinase modulators

#41
20140079834
2014-03-20

Bioactive fractions and compounds from for the prevention or treatment of osteo-health related disorders

#42
20140005149
2014-01-02

Substituted diphenyl derivatives

#43
20130281652
2013-10-24

Functionalized phenolic compounds and polymers therefrom

#44
20130231325
2013-09-05

ALDH-2 inhibitors in the treatment of addiction

#45
20130190392
2013-07-25

Method of preparing soy isoflavone nanoparticles by precipitation with compressed antisolvent (PCA) using a supercritical fluid

#46
20130079393
2013-03-28

Isoflavone fatty acid ester derivatives, preparation method and pharmaceutical uses thereof

#47
20130053436
2013-02-28

Compounds, compositions and methods

#48
20130029901
2013-01-31

METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH

#49
20120295966
2012-11-22

Chromone inhibitors of S-nitrosoglutathione reductase

#50
20120289555
2012-11-15

S-nitrosoglutathione reductase inhibitors

#51
20120289496
2012-11-15

Compounds as modulators of protein kinases

#52
20120283313
2012-11-08

INHIBITION AND TREATMENT OF PROSTATE CANCER METASTASIS

#53
20120209012
2012-08-16

Compounds, compositions and methods

#54
20120190847
2012-07-26

Triarylmethane analogs and their use in treating cancers

#55
20120114639
2012-05-10

COMPOSITIONS AND METHODS FOR INHIBITING VIRAL AND/OR BACTERIAL INFECTIONS

#56
20120083440
2012-04-05

METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH

#57
20120059001
2012-03-08

4H-chromen-4-one compounds as modulators of protein kinases

#58
20120003273
2012-01-05

Substituted benzfurochromenes and related compounds for the prevention and treatment of bone related disorders

#59
20110262482
2011-10-27

Isoflavone anti-viral compounds

#60
20110237659
2011-09-29

CHROMENONE DERIVATIVES AS TRPV3 ANTAGONISTS

#61
20110230550
2011-09-22

Compounds, compositions and methods

#62
20110166142
2011-07-07

2-SUBSTITUTED ISOFLAVONOID COMPOUNDS, MEDICAMENTS AND USES

#63
20110118257
2011-05-19

2,3-disubstituted chromen-4-one compounds as modulators of protein kinases

#64
20110082176
2011-04-07

Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases

#65
20110076368
2011-03-31

Soy beverage substantially free of isoflavones and method of production

#66
20110046214
2011-02-24

COMPOSITION INHIBITING SEX HORMONE-BINDING GLOBULIN

#67
20100261916
2010-10-14

Method for resolution of a mixture of pinocembrin optical isomers, especially a pinocembrin racemate

#68
20100234310
2010-09-16

ESTROGENIC COMPOUNDS AND THEIR METHODS OF USE

#69
20100191003
2010-07-29

Method for producing glycoside aglycone

#70
20100189762
2010-07-29

TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS

#71
20100160296
2010-06-24

Use of imipramine blue and analogs thereof in treating cancers

#72
20100152284
2010-06-17

PREVENTION AND REVERSAL OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY

#73
20100113592
2010-05-06

Unsymmetrical aromatic ether diacids and absorbable polymers therefrom

#74
20100105767
2010-04-29

Compounds, compositions and methods

#75
20100069478
2010-03-18

Isoflavone derivatives and uses thereof

#76
20100029758
2010-02-04

DERIVATIVES OF ISOFLAVONES

#77
20090287001
2009-11-19

Process for the manufacture of hydroxylated isoflavones

#78
20090259048
2009-10-15

Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases

#79
20090233999
2009-09-17

COMPOSITIONS AND THERAPEUTIC METHODS INVOLVING ISOFLAVONES AND ANALOGUES THEREOF

#80
20090215767
2009-08-27

Isoflavone derivatives and pharmaceutical compositions comprising the same

#81
20090209533
2009-08-20

ALDH-2 inhibitors in the treatment of addiction

#82
20090192152
2009-07-30

Novel Antigiardial Agents and Methods of Use Thereof

#83
20090176871
2009-07-09

Treatments for Domestic Animals Having Sex Hormone Deficiencies Using Soy Germ Isoflavones

#84
20090176745
2009-07-09

TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS

#85
20090170927
2009-07-02

Functionalized sinapic acid and methyl sinapate

#86
20090124569
2009-05-14

INHIBITION AND TREATMENT OF PROSTATE CANCER METASTASIS

#87
20090118164
2009-05-07

Methods and compounds for the targeted delivery of agents to bone for interaction therewith

#88
20090060979
2009-03-05

Controlled release of biologically active compounds

#89
20090005580
2009-01-01

Compounds, compositions and methods

#90
20080207610
2008-08-28

ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION

#91
20080161385
2008-07-03

Composition Inhibiting Sex Hormone-Binding Globulin

#92
20080114056
2008-05-15

Chromone Derivatives Useful as Vanilloid Antagonists

#93
20080032995
2008-02-07

ALDH-2 INHIBITORS IN THE TREATMENT OF DRUG ADDICTION

#94
20080014249
2008-01-17

Compositions and therapeutic methods involving isoflavones and analogues thereof

#95
20070232661
2007-10-04

Hedgehog pathway antagonists

#96
20070141113
2007-06-21

Unsymmetrical aromatic ether diacids and absorbable polymers therefrom

#97
20070123566
2007-05-31

Isoflavone derivatives of tectorigenin, the preparation thereof and the antiviral medicine containing the same as an effective constituent

#98
20070099826
2007-05-03

Treatment of diseases associated with the egr-1 enhancer element

#99
20060251592
2006-11-09

Isoflavone derivatives

#100
20060247305
2006-11-02

Chromen-4-one inhibitors of anti-apoptotic Bcl-2 family members and the uses thereof

#101
20060241173
2006-10-26

Compound

#102
20060217564
2006-09-28

Production of isoflavone derivatives

#103
20060205792
2006-09-14

Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases

#104
20060205767
2006-09-14

Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases

#105
20060106220
2006-05-18

Compositions and therapeutic methods involving isoflavones and analogues thereof

#106
20060106091
2006-05-18

Antigiardial agents and use thereof

#107
20060068042
2006-03-30

Method for producing soluble composition containing isoflavones

#108
20060067903
2006-03-30

Reduction of hair growth

#109
20060052440
2006-03-09

Medicinal composition for treating sudden deafness

#110
20060020008
2006-01-26

Compounds, compositions and methods

#111
20050256321
2005-11-17

Manufacture of isoflavones

#112
20050220753
2005-10-06

Hydrophilic polymers-flavoids conjugates and pharmaceutical compositions comprising them

#113
20050202139
2005-09-15

Recovery of isoflavones from aqueous mixtures using zeolites or molecular sieves

#114
20050175751
2005-08-11

Method of extracting isoflavon from soybeans

#115
20050143588
2005-06-30

Production of isoflavone derivatives

#116
20050123633
2005-06-09

Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon

#117
20050096381
2005-05-05

Derivatives of isoflavones

#118
20050049424
2005-03-03

6-Hydroxy isoflavones derivatives and medicaments involving same

#119
20050043350
2005-02-24

Estrogen receptor-β ligands